However, increased production of the C-terminal fragment of NLRP1, such as during viral infection, is thought to decrease intact NLRP1, rendering this DPP9 checkpoint dysfunctional, resulting in the release of the C-terminal fragment, which in turn leads to NLRP1 activation. The gene discussed is NLRP1; the disease is viral infectious disease.